163 related articles for article (PubMed ID: 28861783)
1. Analysis of miRNA Signatures in Neurodegenerative Prion Disease.
Bellingham SA; Hill AF
Methods Mol Biol; 2017; 1658():67-80. PubMed ID: 28861783
[TBL] [Abstract][Full Text] [Related]
2. microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD).
Pogue AI; Lukiw WJ
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502105
[TBL] [Abstract][Full Text] [Related]
3. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
4. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells.
Bellingham SA; Coleman BM; Hill AF
Nucleic Acids Res; 2012 Nov; 40(21):10937-49. PubMed ID: 22965126
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease.
Toivonen JM; Sanz-Rubio D; López-Pérez Ó; Marín-Moreno A; Bolea R; Osta R; Badiola JJ; Zaragoza P; Espinosa JC; Torres JM; Martín-Burriel I
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32549330
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in Prion Diseases-From Molecular Mechanisms to Insights in Translational Medicine.
Contiliani DF; Ribeiro YA; de Moraes VN; Pereira TC
Cells; 2021 Jun; 10(7):. PubMed ID: 34209482
[TBL] [Abstract][Full Text] [Related]
7. Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging?
Sobrova P; Blazkova I; Chomoucka J; Drbohlavova J; Vaculovicova M; Kopel P; Hubalek J; Kizek R; Adam V
Prion; 2013; 7(5):349-58. PubMed ID: 24055838
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of prion-induced neurodegeneration.
Saá P; Harris DA; Cervenakova L
Expert Rev Mol Med; 2016 Apr; 18():e5. PubMed ID: 27055367
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles--Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases.
Coleman BM; Hill AF
Semin Cell Dev Biol; 2015 Apr; 40():89-96. PubMed ID: 25704308
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases.
Machida A; Ohkubo T; Yokota T
Methods Mol Biol; 2013; 1024():203-9. PubMed ID: 23719953
[TBL] [Abstract][Full Text] [Related]
11. microRNA-146a as a biomarker for transmissible spongiform encephalopathy.
Pogue A; Zhao Y; Lukiw W
Folia Neuropathol; 2022; 60(1):24-34. PubMed ID: 35359143
[TBL] [Abstract][Full Text] [Related]
12. Prion-like proteins and their computational identification in proteomes.
Batlle C; Iglesias V; Navarro S; Ventura S
Expert Rev Proteomics; 2017 Apr; 14(4):335-350. PubMed ID: 28271922
[TBL] [Abstract][Full Text] [Related]
13. Prions: protein aggregation and infectious diseases.
Aguzzi A; Calella AM
Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
[TBL] [Abstract][Full Text] [Related]
14. Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease.
Pearce MM
Curr Opin Genet Dev; 2017 Jun; 44():149-155. PubMed ID: 28441621
[TBL] [Abstract][Full Text] [Related]
15. Decreased cell surface prion protein in mouse models of prion disease.
Griffin JK; Terry LA; Jackman R; Yousefi M; Cashman NR
Neuroreport; 2007 Jan; 18(1):1-6. PubMed ID: 17259851
[TBL] [Abstract][Full Text] [Related]
16. Current and future molecular diagnostics for prion diseases.
Lehto MT; Peery HE; Cashman NR
Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033
[TBL] [Abstract][Full Text] [Related]
17. [The non-conventional transmissible agents at the origin of transmissible subacute spongiform encephalopathies].
Dormont D
Therapie; 1998; 53(2):93-100. PubMed ID: 9773107
[TBL] [Abstract][Full Text] [Related]
18. A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression.
Wang WX; Fardo DW; Jicha GA; Nelson PT
Mol Neurobiol; 2017 Dec; 54(10):8191-8202. PubMed ID: 27900678
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mouse models of prion diseases.
Telling GC
Methods Mol Biol; 2008; 459():249-63. PubMed ID: 18576160
[TBL] [Abstract][Full Text] [Related]
20. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
Jeffrey M; McGovern G; Sisó S; González L
Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
